1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. HOTH THERAPEUTICS INC

Hoth Therapeutics Inc

XNAS: HOTH

Download real time

1.08 0.01 (0.93%)

71.58% Fall from 52W High

167.3K XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
14S
5W
0O
3T
14.2

Market Cap

Low in industry
-1.9

PE TTM

Negative PE TTM
-0.1

PEG TTM

PEG TTM is negative
1.9

Price to Book

Below industry Median
-0.5

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Hoth Therapeutics Inc is on 28 Mar 2025 for the purpose of Hoth Therapeutics Inc Annual Report for 2024 See details


Insider Trading disclosures for Hoth Therapeutics Inc

The latest disclosure was made by Graig Springer in Hoth Therapeutics Inc where a trade of 70,000 Options done was reported to US exchanges on Jan. 14, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2025 70,000 70,000 - - Options
Robb Knie Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2025 7,000 7,000 - - Options
Robb Knie Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2025 93,000 93,000 - - Options
Jeff Pavell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2024 25,000 25,000 - - Options
Wayne D. Linsley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2024 25,000 25,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2024 25,000 25,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2024 48,000 48,000 - - Options
David B. Sarnoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2024 25,000 25,000 - - Options
Robb Knie Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Aug 2024 325,000 325,000 - - Options
Robb Knie Director, CEO and President Purchase of securities on an exchange or from another person at price $ 0.67 per share. 16 Aug 2024 25,000 58,131 (0%) 0% 0.7 16,750 Common Stock
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 25,000 25,000 - - Options
D. Wayne Linsley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 25,000 25,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 100,000 100,000 - - Options
Pavell Jeff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 25,000 25,000 - - Options
Sarnoff David B. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 25,000 25,000 - - Options
Knie Robb Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jan 2024 225,000 225,000 - - Options
Jeff Pavell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2023 7,500 7,500 - - Options
Wayne D. Linsley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2023 7,500 7,500 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2023 20,000 20,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2023 7,500 7,500 - - Options
David B. Sarnoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2023 7,500 7,500 - - Options
Robb Knie Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2023 40,000 40,000 - - Options
Robb Knie Director, CEO and President Purchase of securities on an exchange or from another person at price $ 0.39 per share. 19 Sep 2022 10,000 828,259 (8%) 0% 0.4 3,900 Common Stock
Robb Knie Director, CEO and President Purchase of securities on an exchange or from another person at price $ 0.40 per share. 16 Sep 2022 10,000 818,259 (8%) 0% 0.4 4,000 Common Stock
Robb Knie Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2022 500,000 500,000 - - Options
David B. Sarnoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2022 40,000 40,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2022 250,000 250,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2022 40,000 40,000 - - Options
Wayne D. Linsley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2022 40,000 40,000 - - Options
Stefanie Johns Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2022 250,000 250,000 - - Options
Wayne Linsley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2021 33,000 33,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2021 150,000 150,000 - - Options
Vadim Mats Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2021 33,000 33,000 - - Options
Robb Knie Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2021 225,000 225,000 - - Options
David B. Sarnoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2021 33,000 33,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2021 33,000 33,000 - - Options
Stefanie Johns Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jan 2021 125,000 125,000 - - Options
Kenneth L. Rice Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2020 15,000 15,000 - - Options
Vadim Mats Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2020 15,000 15,000 - - Options
Robb Knie Director, CEO and President Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2020 80,000 80,000 - - Options
Wayne Linsley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2020 15,000 15,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2020 45,000 45,000 - - Options
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2020 15,000 15,000 - - Options
David B. Sarnoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jul 2020 15,000 15,000 - - Options
Anthony Hayes Ten Percent Owner Sale of securities on an exchange or to another person at price $ 1.25 per share. 26 May 2020 400,000 1,130,674 (11%) - 1.3 500,000 Common Stock, par value $0.0001
Graig Springer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2020 3,333 3,333 (0%) 0% - Common Stock
Wayne Linsley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Apr 2020 3,333 3,333 (0%) 0% - Common Stock
Anthony Hayes Director 31 Dec 2019 9,226 1,600,516 (15%) 0% 0 Common Stock
Robb Knie Director, CEO and President 31 Dec 2019 85 808,255 (7%) 0% 0 Common Stock
Anthony Hayes Director 31 Dec 2019 90,258 1,609,742 (15%) 0% 0 Common Stock
Anthony Hayes Director 31 Dec 2019 301 105,301 (1%) 0% 0 Common Stock
David B. Sarnoff Director Other type of transaction at price $ 0.00 per share. 24 Dec 2019 35,000 35,000 - - Options
Robb Knie Director, CEO and President Other type of transaction at price $ 0.00 per share. 24 Dec 2019 250,000 250,000 - - Options
Anthony Hayes Director Other type of transaction at price $ 0.00 per share. 24 Dec 2019 35,000 35,000 - - Options
Vadim Mats Director Other type of transaction at price $ 0.00 per share. 24 Dec 2019 35,000 35,000 - - Options
Kenneth L. Rice Director Other type of transaction at price $ 0.00 per share. 24 Dec 2019 35,000 35,000 - - Options
David S. Briones Chief Financial Officer Other type of transaction at price $ 0.00 per share. 06 Mar 2019 50,000 50,000 - - Options
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters